In re Am. Bd. of Med. Specialties Maint. of Certification Antitrust Litig.
Opinion of the Court
Before the Panel: Plaintiffs in the Mannis action listed on Schedule A move under
On the basis of the papers filed and the hearing held, we conclude that centralization will not serve the convenience of the parties and witnesses or further the just and efficient conduct of this litigation. Where only a minimal number of actions are involved, the proponent of centralization bears a heavier burden to demonstrate that centralization is appropriate. See In re Transocean Ltd. Sec. Litig. (No. II) ,
These actions involve similar allegations that defendants, which offer certification in various medical specialties, require physicians to purchase and participate in "maintenance of certification" programs in order to maintain their initial board certifications. Plaintiffs allege that this constitutes an unlawful tying arrangement in violation of antitrust laws. The similarities, though, end there. Each action names different medical certification boards as defendants, and each is brought on behalf of a different, *1354non-overlapping putative class of physicians.
To the extent these actions may involve duplicative discovery (particularly with respect to ABMS), alternatives to centralization appear eminently feasible. Defendants in the Mannis litigation, which is pending in the Southern District of California, have moved (in the alternative to dismissal) for transfer of that action to the Northern District of Illinois pursuant to
Even if transfer is denied, this litigation involves only four actions pending in three districts, and plaintiffs in three of the actions share counsel. Informal cooperation among the relatively few involved attorneys and coordination among the involved courts therefore are practicable alternatives to centralization. Indeed, defendants represented in their briefs to the Panel their willingness to coordinate with plaintiffs to minimize any potential for duplicative discovery or inconsistent pretrial rulings. See, e.g. , In re Eli Lilly & Co. (Cephalexin Monohydrate) Patent Litig. ,
IT IS THEREFORE ORDERED that the motion for centralization of these actions is denied.
SCHEDULE A
MDL No. 2888 - IN RE: AMERICAN BOARD OF MEDICAL SPECIALTIES MAINTENANCE OF CERTIFICATION ANTITRUST LITIGATION
Southern District of California
MANNIS, ET AL. v. AMERICAN BOARD OF MEDICAL SPECIALTIES, ET AL., C.A. No. 3:19-00341
Northern District of Illinois
SIVA v. AMERICAN BOARD OF RADIOLOGY, C.A. No. 1:19-01407
Eastern District of Pennsylvania
KENNEY, ET AL. v. AMERICAN BOARD OF INTERNAL MEDICINE, C.A. No. 2:18-05260
Movants insist that the Mannis action encompasses the claims and classes in the other actions, because movants assert claims against the American Board of Medical Specialties (ABMS), the umbrella organization for the various medical specialty boards named in these actions. Non-moving plaintiffs and defendants, though, uniformly maintain (and at oral argument, movants conceded) that ABMS does not itself certify physicians. Thus, the putative class in each action appears to encompass only those physicians certified by the unique medical certification board defendants named in each action.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.